Nebulized Epinephrine vs. Salbutamol in Bronchiolitis Among Children

• Status: Recruiting
• Trial end date: 2020-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Acute bronchiolitis, mostly secondary to infection due to Respiratory syncytial virus (RSV) is very common in infants under two years old. It is usually benign. However, the dyspnea it causes is a big concern for parents and this disease can take a severe form on certain particular ground thus constituting a frequent reason for hospitalization in pediatrics. Nebulized epinephrine showed more efficacy than nebulized salbutamol.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Makassed General Hospital
• Treatments: Albuterol; Epinephrine; Epinephryl borate; Racepinephrine

Criteria

Inclusion Criteria:

• Children diagnosed with acute bronchiolitis.

Exclusion Criteria:

• Children with congenital heart disease or

• chronic lung diseases